Assessing the associations between immunosuppressant use and COVID-19 severity in patients with autoimmune hepatitis

Table 2 Adjusted logistic regression for associations between immunosuppression type and severe acute respiratory syndrome coronavirus 2 infection

Immunosuppressant	Odds ratio	P value	95%CI
Prednisone	0.81	0.04	0.65-0.99
Azathioprine	0.98	0.84	0.78-1.21
Budesonide	0.77	0.22	0.50-1.15
Tacrolimus	0.66	0.06	0.41-0.99
Mycophenolate mofetil	1.32	0.47	0.59-2.61
Cyclosporine	0.81	0.44	0.44-1.35
Azathioprine × budesonide	1.88	0.04	1.02-3.44
Prednisone × azathioprine	1.06	0.78	0.72-1.54
Prednisone × budesonide	1.25	0.50	0.65-2.32
Budesonide × mycophenolate mofetil	0.84	0.87	0.04-5.23
Prednisone × mycophenolate mofetil	0.64	0.42	0.21-1.88
Budesonide × tacrolimus	0.80	0.73	0.18-2.47
Prednisone × tacrolimus	1.99	0.02	1.14-3.53